Susquehanna Fundamental Investments LLC acquired a new position in Oracle Co. (NYSE:ORCL – Free Report) during the second quarter, according to the company in its most recent filing with the SEC. The fund acquired 10,740 shares of the enterprise software provider’s stock, valued at approximately $1,516,000.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in ORCL. Security National Bank of SO Dak boosted its stake in shares of Oracle by 1.6% during the 2nd quarter. Security National Bank of SO Dak now owns 32,192 shares of the enterprise software provider’s stock valued at $4,546,000 after buying an additional 513 shares during the last quarter. Legal & General Group Plc raised its holdings in Oracle by 2.3% in the second quarter. Legal & General Group Plc now owns 13,242,340 shares of the enterprise software provider’s stock valued at $1,869,816,000 after acquiring an additional 296,866 shares in the last quarter. Matrix Private Capital Group LLC bought a new position in Oracle during the 2nd quarter valued at $217,000. Maverick Capital Ltd. grew its holdings in Oracle by 37.5% during the 2nd quarter. Maverick Capital Ltd. now owns 17,122 shares of the enterprise software provider’s stock worth $2,418,000 after acquiring an additional 4,668 shares in the last quarter. Finally, MBB Public Markets I LLC increased its position in shares of Oracle by 1,903.0% in the 2nd quarter. MBB Public Markets I LLC now owns 149,244 shares of the enterprise software provider’s stock worth $21,073,000 after purchasing an additional 141,793 shares during the last quarter. 42.44% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling at Oracle
In other news, insider Edward Screven sold 426,861 shares of Oracle stock in a transaction on Wednesday, July 10th. The stock was sold at an average price of $141.91, for a total transaction of $60,575,844.51. Following the transaction, the insider now owns 2,626,764 shares in the company, valued at $372,764,079.24. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other Oracle news, insider Edward Screven sold 426,861 shares of Oracle stock in a transaction dated Wednesday, July 10th. The stock was sold at an average price of $141.91, for a total transaction of $60,575,844.51. Following the transaction, the insider now owns 2,626,764 shares of the company’s stock, valued at approximately $372,764,079.24. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Chairman Lawrence Joseph Ellison sold 1,125,000 shares of the company’s stock in a transaction dated Monday, July 15th. The shares were sold at an average price of $143.69, for a total value of $161,651,250.00. Following the completion of the transaction, the chairman now owns 1,145,732,353 shares in the company, valued at approximately $164,630,281,802.57. The disclosure for this sale can be found here. Insiders have sold a total of 1,573,181 shares of company stock valued at $225,338,245 in the last three months. 42.80% of the stock is currently owned by company insiders.
Oracle Stock Performance
Oracle (NYSE:ORCL – Get Free Report) last posted its quarterly earnings data on Monday, September 9th. The enterprise software provider reported $1.39 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.33 by $0.06. Oracle had a return on equity of 171.38% and a net margin of 20.40%. The firm had revenue of $13.31 billion for the quarter, compared to the consensus estimate of $13.23 billion. During the same quarter in the previous year, the company earned $0.95 EPS. The business’s revenue for the quarter was up 6.9% compared to the same quarter last year. As a group, sell-side analysts forecast that Oracle Co. will post 5.01 earnings per share for the current fiscal year.
Oracle Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 24th. Shareholders of record on Thursday, October 10th will be given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 0.96%. The ex-dividend date is Thursday, October 10th. Oracle’s payout ratio is 43.13%.
Wall Street Analyst Weigh In
Several brokerages have recently commented on ORCL. Deutsche Bank Aktiengesellschaft increased their price target on shares of Oracle from $150.00 to $165.00 and gave the stock a “buy” rating in a research report on Monday, June 17th. TD Cowen lifted their target price on Oracle from $165.00 to $180.00 and gave the stock a “buy” rating in a research report on Tuesday, September 10th. StockNews.com raised Oracle from a “hold” rating to a “buy” rating in a research report on Tuesday, September 10th. Oppenheimer reaffirmed a “market perform” rating on shares of Oracle in a report on Tuesday, September 10th. Finally, Stifel Nicolaus increased their target price on shares of Oracle from $135.00 to $155.00 and gave the stock a “hold” rating in a report on Tuesday, September 10th. Ten investment analysts have rated the stock with a hold rating and twenty have assigned a buy rating to the stock. According to MarketBeat.com, Oracle currently has a consensus rating of “Moderate Buy” and an average target price of $167.42.
Check Out Our Latest Stock Analysis on ORCL
Oracle Profile
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
Featured Stories
- Five stocks we like better than Oracle
- What is the Euro STOXX 50 Index?
- Why Lennar Stock Could Be the Best Play in the Housing Market
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- 2 Energy Stocks Fueling the AI Datacenter Boom
- Trading Halts Explained
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Co. (NYSE:ORCL – Free Report).
Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.